Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Risperdal 500microgram tablets
040201030BBAGAK
|
Risperdal | Risperidone | Central Nervous System | 225 |
|
Risperdal 1mg tablets
040201030BBAAAA
|
Risperdal | Risperidone | Central Nervous System | 179 |
|
Risperdal 2mg tablets
040201030BBABAB
|
Risperdal | Risperidone | Central Nervous System | 163 |
|
Risperdal 1mg/ml oral solution
040201030BBAEAE
|
Risperdal | Risperidone | Central Nervous System | 82 |
|
Risperdal 3mg tablets
040201030BBACAC
|
Risperdal | Risperidone | Central Nervous System | 73 |
|
Risperdal 4mg tablets
040201030BBADAD
|
Risperdal | Risperidone | Central Nervous System | 72 |
|
Risperdal 6mg tablets
040201030BBAFAF
|
Risperdal | Risperidone | Central Nervous System | 18 |
|
Risperdal Quicklet 1mg orodispersible tablets
040201030BBAHAL
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 2mg orodispersible tablets
040201030BBAIAM
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 3mg orodispersible tablets
040201030BBAKAP
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 4mg orodispersible tablets
040201030BBALAQ
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 500microgram orodispersible tablets
040201030BBAJAN
|
Risperdal | Risperidone | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.